Dr. du Bois on Study of Secondary Cytoreductive Surgery in Ovarian Cancer | OncLive

Dr. du Bois on Study of Secondary Cytoreductive Surgery in Ovarian Cancer

August 2, 2017

Andreas du Bois, MD, PhD, a professor of gynecologic oncology at Kliniken Essen Mitte, discusses his study of secondary cytoreductive surgery in ovarian cancer.

Andreas du Bois, MD, PhD, a professor of gynecologic oncology at Kliniken Essen Mitte, discusses his study of secondary cytoreductive surgery in ovarian cancer.

In a randomized controlled phase III study, investigators evaluated the impact of secondary cytoreductive surgery in patients with recurrent ovarian cancer.


x